Friesen Prize Lecture: Dr. Lorne Tyrrell on Contributions to Viral Hepatitis, Vaccine Task Force and COVID-19
Tuesday, February 28, 2023
Lecture 2-3pm | Reception 3-4pm
Dr. Lorne Tyrrell
OC, AOE, MD, PhD, FRCP, FRSC, FCAHS
Distinguished Professor at the University of Alberta
Recipient of the 2021 Henry G. Friesen International Prize in Health Research
In person at the
Jack Poole Hall, Robert H. Lee Alumni Centre
6163 University Boulevard
RSVP REQUIRED – PLEASE REGISTER BELOW
Venue parking and accessibility information
Dr. David Lorne J. Tyrrell is a visionary clinician-scientist, creative virologist, entrepreneur and academic leader. His most celebrated life-saving accomplishment, in collaboration with Morris Robbins, was the licensing of the first oral anti-viral drug for chronic hepatitis B (Lamivudine) in 200 countries. This led to the establishment of the Li Ka Shing Institute of Virology in 2010 at the University of Alberta, where Dr. Tyrrell is its Founder and Director.
The Henry G. Friesen International Prize in Health Research, established in 2005 by the Friends of Canadian Institutes of Health Research (FCIHR), recognizes exceptional innovation by a visionary health leader of international stature.
